Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Amneal Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
AMRX
Nasdaq
8731
https://amneal.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Amneal Pharmaceuticals Inc
Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension
- Mar 25th, 2024 8:05 pm
Amneal Pharmaceuticals Inc (AMRX) Reports Mixed 2023 Financial Results
- Mar 1st, 2024 11:32 am
Amneal Reports Fourth Quarter and Full Year 2023 Financial Results
- Mar 1st, 2024 11:00 am
Amneal Enters into Exclusive European Licensing Agreement with Zambon Biotech for IPX203
- Feb 27th, 2024 1:00 pm
Insiders the biggest winners as Amneal Pharmaceuticals, Inc.'s (NASDAQ:AMRX) market cap rises to US$1.8b
- Feb 18th, 2024 1:33 pm
Amneal to Participate at Upcoming Investor Conference
- Feb 13th, 2024 1:00 pm
Amneal Announces Complete Response Resubmission for IPX203 New Drug Application
- Feb 8th, 2024 9:05 pm
Amneal to Report Fourth Quarter and Full Year 2023 Results on March 1, 2024
- Jan 31st, 2024 9:05 pm
Knight Therapeutics Enters into Exclusive License Agreement with Amneal Pharmaceuticals for IPX203
- Jan 25th, 2024 12:30 pm
Amneal Launches Complex Generic Fluorometholone Ophthalmic Suspension
- Jan 10th, 2024 1:00 pm
Amneal Launched Record Number of 39 New Retail and Injectable Products in 2023, Including 13 in Q4 2023
- Jan 4th, 2024 9:05 pm
Amneal to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
- Dec 21st, 2023 1:00 pm
Amneal Announces Move to Nasdaq
- Dec 15th, 2023 9:05 pm
Amneal and BIAL Announce U.S. Licensing Agreement for ONGENTYS® (opicapone)
- Dec 7th, 2023 1:00 pm
Amneal Expands Portfolio with Addition of Icosapent Ethyl Acid Soft Gel Capsules
- Dec 1st, 2023 1:00 pm
Should You Be Excited About Amneal Pharmaceuticals, Inc.'s (NYSE:AMRX) 20% Return On Equity?
- Nov 27th, 2023 10:51 am
Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year?
- Nov 10th, 2023 2:40 pm
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q3 2023 Earnings Call Transcript
- Nov 8th, 2023 10:57 pm
Amneal (AMRX) Reports Q3 Earnings: What Key Metrics Have to Say
- Nov 7th, 2023 2:30 pm
Amneal Pharmaceuticals Inc (AMRX) Reports 14% Increase in Q3 2023 Net Revenue
- Nov 7th, 2023 12:04 pm
Scroll